4 results on '"Skrzypczak, Piotr"'
Search Results
2. Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study.
- Author
-
Gabryel, Piotr, Skrzypczak, Piotr, Roszak, Magdalena, Campisi, Alessio, Zielińska, Dominika, Bryl, Maciej, Stencel, Katarzyna, and Piwkowski, Cezary
- Subjects
- *
LUNG cancer , *RESEARCH , *LYMPHADENECTOMY , *CONFIDENCE intervals , *MULTIPLE regression analysis , *MINIMALLY invasive procedures , *METASTASIS , *RETROSPECTIVE studies , *ACQUISITION of data , *EARLY detection of cancer , *POSITRON emission tomography computed tomography , *TUMOR classification , *COMPARATIVE studies , *QUALITY assurance , *MEDICAL records , *DESCRIPTIVE statistics , *ODDS ratio , *VIDEO-assisted thoracic surgery , *LONGITUDINAL method , *DISEASE complications - Abstract
Simple Summary: The excision of the lymph nodes, known as lymphadenectomy, is an essential part of surgical operation for lung cancer. This nationwide study was conducted to identify factors influencing the quality of lymphadenectomy. We included 4271 patients who underwent a minimally invasive surgical operation for early-stage lung cancer. Our findings indicate that the requirements for lymphadenectomy were satisfied in 27.9% of patients. Statistical analysis revealed that patients who underwent positron emission tomography–computed tomography before surgery, patients with larger tumors, and those operated on by experienced surgeons had a higher accuracy of lymphadenectomy. Additionally, the study revealed a declining trend in the quality of lymphadenectomy over time. Importantly, more extensive lymph node excision did not correlate with elevated complication rates or in-hospital mortality. In light of these findings, it is imperative to implement actions aimed at enhancing the quality of lymphadenectomy for lung cancer. Lymphadenectomy is an essential part of complete surgical operation for non-small cell lung cancer (NSCLC). This retrospective, multicenter cohort study aimed to identify factors that influence the lymphadenectomy quality. Data were obtained from the Polish Lung Cancer Study Group Database. The primary endpoint was lobe-specific mediastinal lymph node dissection (L-SMLND). The study included 4271 patients who underwent VATS lobectomy for stage IA NSCLC, operated between 2007 and 2022. L-SMLND was performed in 1190 patients (27.9%). The remaining 3081 patients (72.1%) did not meet the L-SMLND criteria. Multivariate logistic regression analysis showed that patients with PET-CT (OR 3.238, 95% CI: 2.315 to 4.529; p < 0.001), with larger tumors (pT1a vs. pT1b vs. pT1c) (OR 1.292; 95% CI: 1.009 to 1.653; p = 0.042), and those operated on by experienced surgeons (OR 1.959, 95% CI: 1.432 to 2.679; p < 0.001) had a higher probability of undergoing L-SMLND. The quality of lymphadenectomy decreased over time (OR 0.647, 95% CI: 0.474 to 0.884; p = 0.006). An analysis of propensity-matched groups showed that more extensive lymph node dissection was not related to in-hospital mortality, complication rates, and hospitalization duration. Actions are needed to improve the quality of lymphadenectomy for NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Predictors of Long-Term Survival of Thoracoscopic Lobectomy for Stage IA Non-Small Cell Lung Cancer: A Large Retrospective Cohort Study.
- Author
-
Gabryel, Piotr, Skrzypczak, Piotr, Campisi, Alessio, Kasprzyk, Mariusz, Roszak, Magdalena, and Piwkowski, Cezary
- Subjects
- *
LUNG cancer , *EVALUATION of medical care , *RESEARCH , *MEDICAL quality control , *STATISTICS , *LYMPHADENECTOMY , *CONFIDENCE intervals , *MULTIVARIATE analysis , *MINIMALLY invasive procedures , *RETROSPECTIVE studies , *ACQUISITION of data , *TREATMENT effectiveness , *MEDICAL records , *DESCRIPTIVE statistics , *THORACOSCOPY , *PROGRESSION-free survival , *ODDS ratio , *DATA analysis , *DATA analysis software , *PNEUMONECTOMY , *LONGITUDINAL method , *PROPORTIONAL hazards models - Abstract
Simple Summary: Lung cancer is a serious and, in many cases, fatal disease. If detected early, it can often be treated successfully. The best treatment results are obtained by a surgical operation which includes removing the part of the lung with the tumor and the excision of the lymph nodes from the chest. The most commonly used measure of treatment effectiveness is the five-year survival. The aim of this study was to identify factors related to 5-year survival after lung cancer surgery. We found that older age, male sex, chronic obstructive pulmonary disease and prolonged postoperative air leak were related to a lower 5-year survival rate. We also found that more accurate lymph node removal was related to a higher 5-year survival rate. These findings provide valuable insights for clinical practice and may contribute to improving the quality of treatment of early-stage NSCLC. The standard of care for patients with early-stage non-small cell lung cancer (NSCLC) is anatomical lung resection with lymphadenectomy. This multicenter, retrospective, cohort study aimed to identify predictors of 5-year survival in patients after thoracoscopic lobectomy for stage IA NSCLC. The study included 1249 patients who underwent thoracoscopic lobectomy for stage IA NSCLC between 17 April 2007, and December 28, 2016. The 5-year survival rate equaled 77.7%. In the multivariate analysis, higher age (OR, 1.025, 95% CI: 1.002 to 1.048; p = 0.032), male sex (OR, 1.410, 95% CI: 1.109 to 1.793; p = 0.005), chronic obstructive pulmonary disease (OR, 1.346, 95% CI: 1.005 to 1.803; p = 0.046), prolonged postoperative air leak (OR, 2.060, 95% CI: 1.424 to 2.980; p < 0.001) and higher pathological stage (OR, 1.271, 95% CI: 1.048 to 1.541; p = 0.015) were related to the increased risk of death within 5 years after surgery. Lobe-specific mediastinal lymph node dissection (OR, 0.725, 95% CI: 0.548 to 0.959; p = 0.024) was related to the decreased risk of death within 5 years after surgery. These findings provide valuable insights for clinical practice and may contribute to improving the quality of treatment of early-stage NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Identification of Factors Related to the Quality of Lymphadenectomy for Lung Cancer: Secondary Analysis of Prospective Randomized Trial Data.
- Author
-
Gabryel, Piotr, Roszak, Magdalena, Skrzypczak, Piotr, Gabryel, Anna, Zielińska, Dominika, Sielewicz, Magdalena, Campisi, Alessio, Kasprzyk, Mariusz, and Piwkowski, Cezary
- Subjects
LYMPHADENECTOMY ,LUNG cancer ,NON-small-cell lung carcinoma ,SECONDARY analysis ,LUNG surgery ,LOGISTIC regression analysis - Abstract
The outcomes of non-small cell lung cancer surgery are influenced by the quality of lymphadenectomy. This study aimed to evaluate the impact of different energy devices on lymphadenectomy quality and identify additional influencing factors. This secondary analysis of the prospective randomized trial data (clinicaltrials.gov: NCT03125798) compared patients who underwent thoracoscopic lobectomy with the LigaSure device (study group, n = 96) and monopolar device (control group, n = 94). The primary endpoint was the lobe-specific mediastinal lymphadenectomy. Lobe-specific mediastinal lymphadenectomy criteria were met in 60.4% and 38.3% of patients in the study and control groups, respectively (p = 0.002). In addition, in the study group, the median number of mediastinal lymph node stations removed was higher (4 vs. 3, p = 0.017), and complete resection was more often achieved (91.7% vs. 80.9%, p = 0.030). Logistic regression analysis indicated that lymphadenectomy quality was positively associated with the use of the LigaSure device (OR, 2.729; 95% CI, 1.446 to 5.152; p = 0.002) and female sex (OR, 2.012; 95% CI, 1.058 to 3.829; p = 0.033), but negatively associated with a higher Charlson Comorbidity Index (OR, 0.781; 95% CI, 0.620 to 0.986; p = 0.037), left lower lobectomy (OR, 0.263; 95% CI, 0.096 to 0.726; p = 0.010) and middle lobectomy (OR, 0.136; 95% CI, 0.031 to 0.606, p = 0.009). This study found that using the LigaSure device can improve the quality of lymphadenectomy in lung cancer patients and also identified other factors that affect the quality of lymphadenectomy. These findings contribute to improving lung cancer surgical treatment outcomes and provide valuable insights for clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.